Abstract:Abstract Biological age is typically estimated using biomarkers whose states have been observed to correlate with chronological age. A persistent limitation of such aging clocks is that it is difficult to establish how the biomarker states are related to the mechanisms of aging. Somatic mutations could potentially form the basis for a more fundamental aging clock since the mutations are both markers and drivers of aging and have a natural timescale. Cell lineage trees inferred from these mutations reflect the somatic evolutionary process, and thus, it has been conjectured, the aging status of the body. Such a timer has been impractical thus far, however, because detection of somatic variants in single cells presents a significant technological challenge. Here, we show that somatic mutations detected using single-cell RNA sequencing (scRNA-seq) from thousands of cells can be used to construct a cell lineage tree whose structure correlates with chronological age. De novo single-nucleotide variants (SNVs) are detected in human peripheral blood mononuclear cells using a modified protocol. A default model based on penalized multiple regression of chronological age on 31 metrics characterizing the phylogenetic tree gives a Pearson correlation of 0.81 and a median absolute error of ~4 years between predicted and chronological ages. Testing of the model on a public scRNA-seq dataset yields a Pearson correlation of 0.85. In addition, cell tree age predictions are found to be better predictors of certain clinical biomarkers than chronological age alone, for instance glucose, albumin levels, and leukocyte count. The geometry of the cell lineage tree records the structure of somatic evolution in the individual and represents a new modality of aging timer. In addition to providing a numerical estimate of “cell tree age,” it unveils a temporal history of the aging process, revealing how clonal structure evolves over life span. Cell Tree Rings complements existing aging clocks and may help reduce the current uncertainty in the assessment of geroprotective trials.

Scale bar of aging trajectories for screening personal rejuvenation treatments

An evaluation of aging measures: from biomarkers to clocks

Models for Evaluation of Biological Age Based on Multi-omics

Development and Validation of Two Composite Aging Measures Using Clinical Biomarkers in the Chinese Population

A Transcriptome-Based Single-Cell Biological Age Model and Resource for Tissue-Specific Aging Measures.

Biologically informed machine learning modeling of immune cells to reveal physiological and pathological aging process

Assessing the rate of aging to monitor aging itself.

Determining a multimodal aging clock in a cohort of Chinese women

Decoding aging clocks: New insights from metabolomics

Next Generation Aging Clock: A Novel Approach to Decoding Human Aging Through Over 3000 Cellular Pathways

Unraveling aging from transcriptomics

Forward single-cell sequencing into clinical application: Understanding of ageing and rejuvenation from clinical observation to single-cell solution

Nonlinear dynamics of multi-omics profiles during human aging

Systems Age: A single blood methylation test to quantify aging heterogeneity across 11 physiological systems

A hematology-based clock derived from the Study of Longitudinal Aging in Mice to estimate biological age

Modeling the human aging transcriptome across tissues, health status, and sex

Three-dimensional facial-image analysis to predict heterogeneity of the human ageing rate and the impact of lifestyle

Epigenomic, Transcriptome And Image-Based Biomarkers Of Aging

Two different aging paths in human blood revealed by integrated analysis of gene Expression, mutation and alternative splicing

Cell Tree Rings: the structure of somatic evolution as a human aging timer